Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.

The primary objective is to determine the efficacy of a strategy of biomarker-guided therapy compared with usual care in high risk patients with left ventricular systolic dysfunction.

本研究的首要目标为明确：针对左心室收缩功能障碍（left ventricular systolic dysfunction）高危患者，采用生物标志物指导治疗（biomarker-guided therapy）策略相较于常规治疗的疗效。